CD8A and rectal cancer: of tumors from 64 rectal cancer patients (33 of whom received NACT), CD8+ T cells increased following NACT, and a higher density of CD8+ T cells was associated with better clinicopathological responses, which demonstrated that T-cell-mediated immune responses play an essential role in the clinicopathological reaction to NACT (115).